Loading...
Header Logo
Keywords
Last Name
Institution

Joel Gore

Concepts (364)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
115
2017
712
11.700
Why?
Acute Coronary Syndrome
39
2017
171
5.620
Why?
Hospitalization
64
2016
640
4.560
Why?
Hospital Mortality
63
2016
523
3.750
Why?
Registries
54
2015
448
3.700
Why?
Aged
167
2017
7234
3.020
Why?
Middle Aged
151
2017
9435
2.550
Why?
Male
172
2017
16590
2.170
Why?
Female
171
2017
18010
2.070
Why?
Massachusetts
58
2016
1503
2.030
Why?
Electrocardiography
28
2015
284
1.920
Why?
Shock, Cardiogenic
11
2016
44
1.770
Why?
Heart Failure
19
2015
425
1.740
Why?
Aged, 80 and over
62
2017
2687
1.720
Why?
Humans
187
2017
33000
1.720
Why?
Coronary Artery Bypass
23
2015
244
1.710
Why?
Thrombolytic Therapy
15
2011
133
1.690
Why?
Angina, Unstable
15
2010
68
1.560
Why?
Heparin
4
2013
95
1.530
Why?
Risk Factors
54
2017
2901
1.500
Why?
Anticoagulants
14
2015
205
1.490
Why?
Hypertension
12
2015
380
1.480
Why?
Hemorrhage
15
2015
151
1.450
Why?
Warfarin
4
2015
73
1.420
Why?
Treatment Outcome
60
2017
2484
1.350
Why?
Time Factors
40
2017
2522
1.280
Why?
Emergency Medical Services
5
2016
124
1.280
Why?
Prognosis
36
2015
836
1.280
Why?
Age Factors
34
2016
1077
1.230
Why?
Risk Assessment
26
2015
1024
1.200
Why?
Incidence
29
2016
749
1.080
Why?
Patient Readmission
6
2015
154
1.070
Why?
Coronary Disease
9
2012
353
1.060
Why?
Inpatients
6
2012
142
1.040
Why?
Thrombocytopenia
2
2012
38
1.020
Why?
Myocardial Reperfusion
4
2011
32
1.020
Why?
Ambulances
2
2012
19
1.020
Why?
Myocardial Revascularization
13
2014
62
0.990
Why?
Retrospective Studies
34
2015
2345
0.980
Why?
Patient Discharge
14
2017
201
0.950
Why?
Fibrinolytic Agents
14
2012
144
0.940
Why?
Multivariate Analysis
26
2017
687
0.940
Why?
Platelet Aggregation Inhibitors
16
2014
222
0.890
Why?
Antihypertensive Agents
8
2015
131
0.890
Why?
Odds Ratio
25
2016
576
0.880
Why?
Survival Rate
24
2015
460
0.860
Why?
Diabetes Mellitus
7
2015
392
0.850
Why?
Logistic Models
19
2016
840
0.820
Why?
Heart Rate
3
2015
217
0.790
Why?
Angiotensin-Converting Enzyme Inhibitors
14
2015
114
0.780
Why?
Adrenergic beta-Antagonists
15
2014
123
0.770
Why?
Sex Factors
16
2015
645
0.750
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
5
2008
70
0.740
Why?
Residence Characteristics
6
2013
161
0.730
Why?
Autonomic Nervous System
1
2015
28
0.720
Why?
Body Mass Index
4
2015
723
0.710
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2014
146
0.710
Why?
Follow-Up Studies
22
2015
1481
0.710
Why?
Venous Thromboembolism
6
2012
90
0.690
Why?
Prospective Studies
25
2015
1572
0.690
Why?
Outcome Assessment (Health Care)
10
2014
430
0.650
Why?
Atrial Fibrillation
5
2012
175
0.650
Why?
Patient Acceptance of Health Care
4
2009
257
0.640
Why?
Heart
1
2015
209
0.630
Why?
Heart Arrest
3
2012
65
0.620
Why?
Acute Disease
23
2015
511
0.610
Why?
Length of Stay
13
2017
396
0.590
Why?
Coronary Artery Disease
5
2015
228
0.590
Why?
Stroke
14
2013
454
0.580
Why?
Kidney Diseases
3
2010
111
0.570
Why?
Transportation of Patients
2
2009
20
0.570
Why?
Insulin Resistance
1
2015
310
0.560
Why?
Ventricular Fibrillation
2
2008
29
0.560
Why?
Chest Pain
2
2010
34
0.550
Why?
Adult
25
2015
9260
0.540
Why?
Recurrence
13
2015
374
0.540
Why?
Myocardial Ischemia
5
2012
109
0.540
Why?
Academic Medical Centers
3
2015
170
0.540
Why?
Stroke Volume
4
2015
183
0.540
Why?
Cardiovascular Agents
9
2013
78
0.540
Why?
Polysaccharides
1
2012
80
0.530
Why?
Comorbidity
17
2015
700
0.530
Why?
Drug Dosage Calculations
1
2010
3
0.530
Why?
Hemangiosarcoma
1
2010
17
0.530
Why?
Pharmacogenetics
1
2010
18
0.520
Why?
Inflammation
2
2015
647
0.520
Why?
Outpatient Clinics, Hospital
1
2010
35
0.520
Why?
Obesity
3
2015
872
0.520
Why?
Heart Neoplasms
1
2010
26
0.520
Why?
Age Distribution
9
2014
221
0.510
Why?
Blood Coagulation
1
2010
33
0.510
Why?
Aspirin
12
2014
158
0.500
Why?
Evidence-Based Medicine
10
2015
294
0.500
Why?
Exercise
1
2015
534
0.500
Why?
Ticlopidine
5
2011
77
0.480
Why?
Practice Guidelines as Topic
7
2015
428
0.480
Why?
Chi-Square Distribution
8
2017
336
0.480
Why?
Blood Glucose
2
2014
388
0.480
Why?
Heparin, Low-Molecular-Weight
3
2010
26
0.460
Why?
Community Health Services
2
2010
103
0.460
Why?
Pulmonary Embolism
4
2010
111
0.450
Why?
Cause of Death
7
2014
113
0.440
Why?
Resuscitation Orders
2
2007
13
0.440
Why?
Sex Distribution
10
2014
217
0.410
Why?
Delivery of Health Care
1
2009
143
0.400
Why?
Survival Analysis
15
2014
363
0.400
Why?
Anticholesteremic Agents
2
2008
40
0.390
Why?
Cholesterol, LDL
2
2007
122
0.380
Why?
Severity of Illness Index
12
2015
804
0.370
Why?
Mortality
5
2012
78
0.360
Why?
Overweight
2
2011
172
0.360
Why?
Stents
8
2012
213
0.360
Why?
Longitudinal Studies
6
2017
693
0.360
Why?
September 11 Terrorist Attacks
1
2005
16
0.350
Why?
Cross-Sectional Studies
8
2015
1182
0.350
Why?
Europe
10
2013
111
0.350
Why?
Patient Transfer
2
2010
39
0.320
Why?
Diabetes Complications
3
2014
94
0.310
Why?
Health Services Accessibility
2
2005
281
0.310
Why?
Venous Thrombosis
4
2013
92
0.300
Why?
South America
7
2013
22
0.290
Why?
Disease Management
6
2009
96
0.290
Why?
Quality of Health Care
3
2010
356
0.290
Why?
North America
7
2013
75
0.290
Why?
Hypercholesterolemia
1
2002
85
0.270
Why?
Secondary Prevention
5
2014
93
0.270
Why?
Coronary Stenosis
2
2011
25
0.260
Why?
Patient Admission
3
2015
105
0.250
Why?
Medical Records
4
2012
114
0.250
Why?
Blood Pressure
6
2011
361
0.250
Why?
Survivors
3
2017
80
0.240
Why?
United States
13
2017
3856
0.240
Why?
New Zealand
8
2013
27
0.230
Why?
Australia
8
2013
48
0.230
Why?
Healthcare Disparities
2
2010
115
0.230
Why?
Calcium Channel Blockers
3
2015
68
0.230
Why?
Clinical Trials as Topic
4
2015
289
0.220
Why?
Anemia
2
2011
60
0.220
Why?
Young Adult
6
2015
2041
0.220
Why?
Drug Therapy, Combination
8
2012
339
0.220
Why?
Societies, Medical
3
2015
146
0.210
Why?
Primary Prevention
3
2014
94
0.210
Why?
Catheterization, Swan-Ganz
2
2009
10
0.210
Why?
Ventricular Function, Left
2
2009
132
0.210
Why?
Cohort Studies
8
2015
1329
0.210
Why?
Canada
6
2015
90
0.210
Why?
Drug Utilization Review
2
2007
52
0.200
Why?
Proportional Hazards Models
7
2014
439
0.200
Why?
Research Design
4
2014
388
0.200
Why?
Algorithms
2
2012
657
0.200
Why?
Arrhythmias, Cardiac
2
2009
70
0.200
Why?
Endpoint Determination
2
2014
24
0.190
Why?
Cardiovascular Diseases
3
2012
544
0.190
Why?
Delayed Diagnosis
1
2016
19
0.190
Why?
Syndrome
9
2007
117
0.190
Why?
Heart Block
2
2008
18
0.190
Why?
Exercise Test
2
2015
146
0.190
Why?
Data Collection
3
2009
367
0.190
Why?
Diuretics
1
2015
31
0.190
Why?
Forecasting
2
2014
161
0.180
Why?
Antiphospholipid Syndrome
1
2014
3
0.180
Why?
Streptokinase
3
2004
8
0.180
Why?
Chronic Disease
2
2015
527
0.170
Why?
Nutrition Surveys
1
2015
92
0.170
Why?
Cardiotonic Agents
2
2015
34
0.170
Why?
Urban Population
1
2015
154
0.170
Why?
Cardiomyopathies
1
2014
58
0.170
Why?
Recovery of Function
1
2015
111
0.170
Why?
Hyperglycemia
1
2014
90
0.170
Why?
Inflammation Mediators
1
2015
132
0.170
Why?
Regression Analysis
5
2010
415
0.170
Why?
Urban Health
2
2015
43
0.170
Why?
C-Reactive Protein
1
2015
170
0.160
Why?
Health Care Surveys
3
2010
232
0.160
Why?
Infusions, Intravenous
2
2011
132
0.160
Why?
Trauma Centers
1
2013
27
0.160
Why?
Thinness
2
2011
26
0.160
Why?
Hospitals, University
1
2013
36
0.160
Why?
Predictive Value of Tests
6
2015
647
0.160
Why?
Brain Ischemia
2
2013
174
0.150
Why?
Disease Progression
5
2014
460
0.150
Why?
Emergency Service, Hospital
3
2011
356
0.150
Why?
Glomerular Filtration Rate
2
2010
63
0.150
Why?
Databases, Factual
2
2012
377
0.150
Why?
Intensive Care Units
2
2011
186
0.150
Why?
Coronary Angiography
5
2010
144
0.150
Why?
Adolescent
4
2015
3942
0.140
Why?
Leg
1
2012
73
0.140
Why?
Treatment Failure
1
2012
111
0.140
Why?
Prevalence
5
2015
778
0.140
Why?
Cerebrovascular Disorders
1
2011
44
0.140
Why?
Hospitals, Community
2
2009
46
0.140
Why?
Postoperative Care
1
2011
70
0.140
Why?
Continuity of Patient Care
2
2014
114
0.140
Why?
Pyridines
2
2009
82
0.140
Why?
Aging
2
2008
517
0.130
Why?
Mixed Function Oxygenases
1
2010
13
0.130
Why?
Aryl Hydrocarbon Hydroxylases
1
2010
16
0.130
Why?
Reproducibility of Results
2
2012
963
0.130
Why?
Vena Cava Filters
1
2010
15
0.130
Why?
International Normalized Ratio
1
2010
34
0.130
Why?
Hypertrophy, Left Ventricular
1
2011
81
0.130
Why?
Hypotension
1
2010
32
0.130
Why?
Drug Prescriptions
2
2010
114
0.130
Why?
Echocardiography
2
2009
193
0.130
Why?
Outcome and Process Assessment (Health Care)
2
2010
181
0.130
Why?
Heart Rupture
1
2010
1
0.130
Why?
Thrombosis
1
2012
150
0.130
Why?
Kidney Failure, Chronic
1
2011
137
0.130
Why?
Infection
1
2010
58
0.130
Why?
Randomized Controlled Trials as Topic
3
2007
310
0.130
Why?
Nitrates
1
2009
13
0.120
Why?
Australasia
2
2013
6
0.120
Why?
Genetic Testing
1
2010
71
0.120
Why?
Professional Practice
1
2009
23
0.120
Why?
Renal Dialysis
1
2011
154
0.120
Why?
Drug Monitoring
1
2010
90
0.120
Why?
Metoprolol
1
2009
16
0.120
Why?
Multicenter Studies as Topic
4
2015
48
0.120
Why?
Smoking
3
2011
788
0.120
Why?
Patient Satisfaction
1
2011
244
0.120
Why?
Gated Blood-Pool Imaging
1
2009
12
0.120
Why?
Pulmonary Disease, Chronic Obstructive
1
2011
133
0.120
Why?
Combined Modality Therapy
4
2015
245
0.120
Why?
Body Weight
1
2011
348
0.120
Why?
Postoperative Complications
2
2011
563
0.120
Why?
Models, Cardiovascular
1
2009
50
0.120
Why?
Confidence Intervals
4
2010
235
0.120
Why?
Genotype
1
2010
486
0.110
Why?
American Heart Association
3
2015
57
0.110
Why?
Tachycardia, Ventricular
1
2008
21
0.110
Why?
Drug-Eluting Stents
1
2009
28
0.110
Why?
Health Services for the Aged
1
2008
33
0.110
Why?
Child
1
2015
2616
0.110
Why?
Time
1
2008
21
0.110
Why?
Dose-Response Relationship, Drug
4
2012
694
0.110
Why?
Angioplasty, Balloon
1
2008
41
0.110
Why?
Risk
1
2008
330
0.110
Why?
Phenotype
1
2010
782
0.110
Why?
Diagnostic Tests, Routine
1
2007
24
0.100
Why?
Enoxaparin
1
2007
12
0.100
Why?
Leukocyte Count
2
2004
76
0.100
Why?
Socioeconomic Factors
2
2015
572
0.100
Why?
Population Surveillance
4
2010
182
0.100
Why?
Administration, Oral
3
2014
203
0.100
Why?
Diabetes Mellitus, Type 2
1
2011
408
0.100
Why?
Peripheral Vascular Diseases
1
2007
45
0.100
Why?
Cardiology
1
2007
74
0.100
Why?
Statistics, Nonparametric
1
2007
164
0.100
Why?
Quality of Life
3
2017
427
0.100
Why?
Tomography, X-Ray Computed
1
2010
725
0.090
Why?
Azetidines
1
2005
4
0.090
Why?
Thrombin
1
2005
48
0.090
Why?
Magnetic Resonance Imaging
1
2010
832
0.090
Why?
District of Columbia
1
2005
10
0.090
Why?
New York City
1
2005
59
0.090
Why?
Drug Utilization
4
2009
144
0.090
Why?
Insurance, Health
2
2002
80
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2009
560
0.090
Why?
Neoplasms
1
2010
583
0.080
Why?
Intracranial Hemorrhages
1
2004
12
0.080
Why?
Resuscitation
1
2004
38
0.080
Why?
Diagnosis, Differential
1
2006
589
0.080
Why?
International Cooperation
1
2004
60
0.080
Why?
Leukocytosis
1
2003
9
0.080
Why?
Propensity Score
2
2014
58
0.080
Why?
Decision Support Techniques
1
2004
93
0.080
Why?
Qualitative Research
1
2004
146
0.080
Why?
Tissue Plasminogen Activator
1
2004
85
0.080
Why?
Nursing Homes
1
2006
284
0.070
Why?
Emergency Medicine
1
2002
74
0.070
Why?
Women's Health
1
2003
289
0.070
Why?
Life Style
2
2015
266
0.070
Why?
Cholesterol
1
2002
257
0.060
Why?
Hispanic Americans
1
2004
363
0.060
Why?
Health Status
2
2017
311
0.060
Why?
Creatinine
2
2010
86
0.060
Why?
Hematocrit
2
2011
40
0.060
Why?
Patient Selection
2
2011
280
0.050
Why?
Case-Control Studies
2
2014
621
0.050
Why?
Disease-Free Survival
1
2017
97
0.050
Why?
Disease Susceptibility
2
2007
92
0.050
Why?
Risk Adjustment
2
2008
70
0.050
Why?
Georgia
1
2015
30
0.050
Why?
Hypertension, Renal
1
2015
8
0.050
Why?
Diet, Sodium-Restricted
1
2015
7
0.050
Why?
Denervation
1
2015
9
0.050
Why?
Blood Pressure Determination
1
2015
20
0.050
Why?
Single-Blind Method
1
2015
66
0.040
Why?
Goals
1
2015
35
0.040
Why?
Internationality
1
2014
25
0.040
Why?
Exercise Therapy
1
2015
37
0.040
Why?
Fatal Outcome
1
2014
78
0.040
Why?
Cost of Illness
1
2015
91
0.040
Why?
Hemodynamics
1
2015
159
0.040
Why?
Americas
2
2004
4
0.040
Why?
Risk Reduction Behavior
1
2015
97
0.040
Why?
Sample Size
1
2014
34
0.040
Why?
Partial Thromboplastin Time
1
2013
11
0.040
Why?
Drug Administration Schedule
1
2014
217
0.040
Why?
Up-Regulation
1
2014
310
0.040
Why?
Cost-Benefit Analysis
1
2014
173
0.040
Why?
Demography
2
2004
151
0.040
Why?
United States Food and Drug Administration
1
2012
42
0.040
Why?
Renal Insufficiency
1
2012
42
0.040
Why?
Nitroglycerin
1
2011
18
0.040
Why?
Furosemide
1
2011
12
0.040
Why?
International Classification of Diseases
1
2012
82
0.040
Why?
Middle East
1
2011
7
0.040
Why?
Clonidine
1
2011
25
0.040
Why?
Perioperative Care
1
2011
36
0.040
Why?
Analysis of Variance
2
2004
529
0.030
Why?
Long-Term Care
1
2012
115
0.030
Why?
Angiotensin II Type 1 Receptor Blockers
1
2010
23
0.030
Why?
Piperazines
1
2011
95
0.030
Why?
Edema
1
2010
26
0.030
Why?
Heart Rupture, Post-Infarction
1
2010
3
0.030
Why?
New England
1
2010
195
0.030
Why?
Ontario
1
2010
21
0.030
Why?
Hematoma, Subdural
1
2009
2
0.030
Why?
Dyspnea
1
2010
45
0.030
Why?
Muscle Cells
1
2009
15
0.030
Why?
Ischemic Preconditioning, Myocardial
1
2009
23
0.030
Why?
Probability
1
2010
146
0.030
Why?
Nomograms
1
2009
5
0.030
Why?
Necrosis
1
2009
90
0.030
Why?
Injections, Intravenous
1
2009
142
0.030
Why?
Hospitals, Urban
1
2009
36
0.030
Why?
Epidemiologic Methods
1
2009
64
0.030
Why?
Cough
1
2010
120
0.030
Why?
Ventricular Dysfunction, Left
1
2009
87
0.030
Why?
Hospitals, Teaching
1
2009
84
0.030
Why?
Critical Care
1
2010
132
0.030
Why?
Adaptation, Psychological
1
2009
158
0.030
Why?
Drug Information Services
1
2007
6
0.030
Why?
Aftercare
1
2007
20
0.030
Why?
Patient Rights
1
2007
16
0.030
Why?
Metabolic Clearance Rate
1
2007
49
0.030
Why?
Laboratories
1
2007
20
0.030
Why?
Life Expectancy
1
2007
16
0.030
Why?
Ultrasonography
1
2008
290
0.030
Why?
Geriatrics
1
2007
24
0.030
Why?
Life Tables
1
2007
24
0.030
Why?
Prejudice
1
2007
43
0.030
Why?
Angina Pectoris
1
2006
44
0.020
Why?
Creatine Kinase, MB Form
1
2006
12
0.020
Why?
Troponin
1
2006
21
0.020
Why?
Creatine Kinase
1
2006
43
0.020
Why?
Drug Therapy
1
2006
47
0.020
Why?
Heart Diseases
1
2007
137
0.020
Why?
Benzylamines
1
2005
9
0.020
Why?
Kidney
1
2007
276
0.020
Why?
Epidemiologic Studies
1
2005
34
0.020
Why?
Thromboembolism
1
2005
39
0.020
Why?
Arthroplasty, Replacement, Hip
1
2005
44
0.020
Why?
Withholding Treatment
1
2004
31
0.020
Why?
Arthroplasty, Replacement, Knee
1
2005
63
0.020
Why?
Cardiac Output, Low
1
2003
8
0.020
Why?
Argentina
1
2002
3
0.020
Why?
Brazil
1
2002
43
0.020
Why?
Blood Vessel Prosthesis Implantation
1
2003
114
0.020
Why?
European Continental Ancestry Group
1
2004
402
0.020
Why?
Social Class
1
2002
76
0.020
Why?
Hospitals
1
2002
172
0.020
Why?
Gore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_